The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27888721 |
14 |
Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation. |
Xinxiang Medical University |
28435523 |
9 |
Discovery of [1,2,3]Triazolo[4,5- |
Key Laboratory of Technology of Drug Preparation (Zhengzhou University) |
28065500 |
8 |
Activation of lysine-specific demethylase 1 inhibitor peptide by redox-controlled cleavage of a traceless linker. |
Nagoya City University |
27046190 |
10 |
Impact of Binding Site Comparisons on Medicinal Chemistry and Rational Molecular Design. |
Tu Dortmund University |
27105028 |
1 |
Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach. |
Zhengzhou University |
26710088 |
248 |
Recent Progress in Histone Demethylase Inhibitors. |
University of Oxford |
26819657 |
8 |
Cyclopropanamine Compounds and Use Thereof. |
Temple University |
26700437 |
32 |
Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators. |
Kyoto Prefectural University of Medicine |
26794039 |
12 |
Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide. |
Waseda University |
26652247 |
60 |
3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1. |
Baylor College of Medicine |
26086931 |
38 |
Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators. |
Shandong University |
25699146 |
13 |
Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell Studies. |
Sapienza University of Rome |
25768700 |
30 |
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts. |
Sapienza University of Rome |
25610955 |
53 |
Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents. |
Zhengzhou University |
25827526 |
33 |
Histone H3 peptide based LSD1-selective inhibitors. |
Waseda University |
25725609 |
18 |
Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures. |
John Hopkins University |
25173853 |
50 |
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A. |
European Institute of Oncology |
24883177 |
10 |
Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1. |
Medical University of South Carolina |
24237195 |
46 |
High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors. |
University of Utah |
24131029 |
90 |
Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration. |
Zhengzhou University |
24007511 |
10 |
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity. |
University of Freiburg |
22876979 |
2 |
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1. |
Wayne State University |
22975593 |
62 |
Oncoepigenomics: making histone lysine methylation count. |
TBA |
20568780 |
2 |
(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators. |
Wayne State University |
21955276 |
60 |
Lysine demethylases inhibitors. |
Kyoto Prefectural University of Medicine |
21596573 |
46 |
Inhibitors of histone demethylases. |
University of Copenhagen |
21382717 |
19 |
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. |
University of Southampton |
21227703 |
3 |
Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor. |
Nagoya City University |
32551003 |
53 |
Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors. |
Constellation Pharmaceuticals |
32201021 |
15 |
4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors. |
Liaocheng University |
32435381 |
33 |
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models. |
European Institute of Oncology Irccs |
32435375 |
22 |
New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes. |
Universidad San Pablo-Ceu |
27524309 |
62 |
Synthesis and biological evaluation of novel (E)-N'-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors. |
Sichuan University |
30739825 |
32 |
Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors. |
Zhengzhou University |
31096156 |
55 |
Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors. |
Zhengzhou University |
30780087 |
32 |
Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors. |
Zhengzhou University |
30713023 |
51 |
Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor. |
Liaoning Shihua University |
30611617 |
15 |
Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking. |
Taizhou People'S Hospital |
30472603 |
11 |
Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors. |
Zhengzhou University |
30850265 |
6 |
Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma. |
West Virginia University |
31627991 |
35 |
Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors. |
Shenyang Pharmaceutical University |
30552007 |
18 |
Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro. |
China Pharmaceutical University |
30448189 |
28 |
Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy. |
Xinxiang Medical University |
30409536 |
50 |
Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors. |
Celgene |
25580204 |
10 |
3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors. |
Medical University of South Carolina |
23293738 |
2 |
Polyamine-based small molecule epigenetic modulators. |
Wayne State University |
24325601 |
74 |
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities. |
Sapienza University of Rome |
19534534 |
3 |
Recent advances in the development of polyamine analogues as antitumor agents. |
Johns Hopkins University |
29247860 |
80 |
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation. |
University of Freiburg |
30153955 |
20 |
Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia. |
Fudan University |
29627262 |
109 |
Structure-based design and discovery of potent and selective KDM5 inhibitors. |
Celgene |
29439916 |
1 |
New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells. |
University of Nevada |
29331452 |
9 |
Design, synthesis and evaluation of ?-turn mimetics as LSD1-selective inhibitors. |
Kyoto Prefectural University of Medicine |
29198865 |
9 |
Histone H3 peptides incorporating modified lysine residues as lysine-specific demethylase 1 inhibitors. |
Waseda University |
29037950 |
21 |
Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation. |
Zhengzhou University |
29152043 |
6 |
Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Potential Treatment for Different Types of Cancers. |
Therachem Research Medilab (India) |
29031059 |
61 |
Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors. |
East China Normal University |
28987602 |
38 |
Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment. |
Xinxiang Medical University |
28927796 |
42 |
Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1. |
University of Manchester |
27769034 |
36 |
Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidines as potent lysine specific demethylase 1 (LSD1/KDM1A) inhibitors. |
Zhengzhou University |
28390942 |
27 |
Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A). |
University of East Anglia |
28610981 |
66 |
3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors. |
Zhengzhou University |
28512031 |
65 |
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors. |
Genentech |
28545974 |
70 |
Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1. |
University of Manchester |
28892629 |
74 |
Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1. |
University of Manchester |
28336409 |
14 |
Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1. |
Nagoya City University |
28460360 |
13 |
Design, synthesis and biological activity of 3-oxoamino-benzenesulfonamides as selective and reversible LSD1 inhibitors. |
China Pharmaceutical University |
25346381 |
6 |
Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking. |
China Pharmaceutical University |
24707965 |
33 |
A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1. |
Johns Hopkins University |
20568732 |
14 |
Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 . |
Riken Systems and Structural Biology Center |